Cargando…

Interleukin‐4 induces a CD44(high)/CD49b(high) PC3 subpopulation with tumor‐initiating characteristics

Pro‐ and anti‐inflammatory cytokines may influence proliferation, migration, invasion, and other cellular events of prostate cancer (PCa) cells. The hyaluronan receptor CD44, which is regulated by Interleukin (IL)‐4, is a prostate basal cell marker. CD44(high)/CD49b(high) expressing cells have been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erb, Holger H.H., Guggenberger, Fabian, Santer, Frédéric R., Culig, Zoran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900863/ https://www.ncbi.nlm.nih.gov/pubmed/29236307 http://dx.doi.org/10.1002/jcb.26607

Ejemplares similares

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
por: Oh, Su Jung, et al.
Publicado: (2012)

Epcam, CD44, and CD49f Distinguish Sphere-Forming Human Prostate Basal Cells from a Subpopulation with Predominant Tubule Initiation Capability
por: Guo, Changyong, et al.
Publicado: (2012)

Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
por: Santer, Frédéric R, et al.
Publicado: (2010)

TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44(high)/CD24(−) Subpopulation
por: Zhang, Chenjing, et al.
Publicado: (2018)

Expression of CD44 in Leukocyte Subpopulations in Patients with Inflammatory Bowel Diseases
por: Franić, Ivana, et al.
Publicado: (2022)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Characterization of the CD49f(+)/CD44(+)/CD24(−) single-cell derived stem cell population in basal-like DCIS cells
por: Duru, Nadire, et al.
Publicado: (2016)

Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44(+)CD133(+) subpopulation of Caco-2 cells
por: Kim, Junghoon, et al.
Publicado: (2021)

IL-10 is Predominantly Produced by CD19(low)CD5(+) Regulatory B Cell Subpopulation: Characterisation of CD19 (high) and CD19(low) Subpopulations of CD5(+) B cells
por: Lee, Jae Ho, et al.
Publicado: (2011)

Profiling of normal and malignant breast tissue show CD44(high)/CD24(low) phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
por: Ghebeh, Hazem, et al.
Publicado: (2013)

CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells
por: Erb, Ulrike, et al.
Publicado: (2014)

Dynamic Changes of CD44 Expression from Progenitors to Subpopulations of Astrocytes and Neurons in Developing Cerebellum
por: Naruse, Masae, et al.
Publicado: (2013)

Olaparib is effective in combination with, and as maintenance therapy after, first‐line endocrine therapy in prostate cancer cells
por: Feiersinger, Gertrud E., et al.
Publicado: (2018)

Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer
por: Zhou, Jin-Yong, et al.
Publicado: (2016)

Cytokines and TLR agonists influence the expression of retention integrins CD49a, CD49b and CD103 by T cells
por: Melssen, Marit M, et al.
Publicado: (2015)

Establishment of oral squamous cell carcinoma cell line and magnetic bead-based isolation and characterization of its CD90/CD44 subpopulations
por: Svobodova, Marketa, et al.
Publicado: (2017)

Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
por: Culig, Zoran, et al.
Publicado: (2012)

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
por: Zhao, Jiang-Sha, et al.
Publicado: (2011)

IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα(2) through IRF9
por: Erb, Holger H H, et al.
Publicado: (2013)

A CD44v(+) subpopulation of breast cancer stem-like cells with enhanced lung metastasis capacity
por: Hu, Jing, et al.
Publicado: (2017)

CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity
por: Kelemen, Andrea, et al.
Publicado: (2022)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan
Publicado: (1996)

CD49f(high) Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors
por: Fukamachi, Hiroshi, et al.
Publicado: (2013)

A CD44(high)/EGFR(low) Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment
por: La Fleur, Linnea, et al.
Publicado: (2012)

CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014)

Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
por: Senbanjo, Linda T., et al.
Publicado: (2019)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
por: Wang, Zhe, et al.
Publicado: (2018)

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling
por: Nappo, G, et al.
Publicado: (2017)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
por: Montero-Montero, Lucía, et al.
Publicado: (2020)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
por: Lin, Z., et al.
Publicado: (2001)

Cell Membrane CD44v6 Levels in Squamous Cell Carcinoma of the Lung: Association with High Cellular Proliferation and High Concentrations of EGFR and CD44v5
por: Ruibal, Álvaro, et al.
Publicado: (2015)

The CD44high Subpopulation of Multifraction Irradiation-Surviving NSCLC Cells Exhibits Partial EMT-Program Activation and DNA Damage Response Depending on Their p53 Status
por: Pustovalova, Margarita, et al.
Publicado: (2021)

Another Notch in CD44
por: Dove, Alan W.
Publicado: (2001)

CD44 in rheumatoid arthritis
por: Naor, David, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_9k4lk1fvuudfiiq384b1ajh133